| Q48486066 | 35Cl dynamic nuclear polarization solid-state NMR of active pharmaceutical ingredients |
| Q45906230 | A 1:2 cocrystal of genistein with isonicotinamide: crystal structure and Hirshfeld surface analysis. |
| Q43513478 | A microfluidic platform for evaporation-based salt screening of pharmaceutical parent compounds |
| Q45836862 | A novel three-dimensional large-pore mesoporous carbon matrix as a potential nanovehicle for the fast release of the poorly water-soluble drug, celecoxib |
| Q41863073 | Analysis of Relationships Between Solid-State Properties, Counterion, and Developability of Pharmaceutical Salts |
| Q88717266 | Antitumoural Sulphur and Selenium Heteroaryl Compounds: Thermal Characterization and Stability Evaluation |
| Q87418853 | Characterization of Solid Dispersion of Itraconazole Prepared by Solubilization in Concentrated Aqueous Solutions of Weak Organic Acids and Drying |
| Q55424195 | Cocrystal of Ibuprofen⁻Nicotinamide: Solid-State Characterization and In Vivo Analgesic Activity Evaluation. |
| Q44523876 | Comparison of a rational vs. high throughput approach for rapid salt screening and selection |
| Q53528770 | Creatinine-based non-phospholipid vesicular carrier for improved oral bioavailability of Azithromycin. |
| Q43119928 | Crystal engineering to improve physicochemical properties of mefloquine hydrochloride. |
| Q43152694 | Crystal morphology engineering of pharmaceutical solids: tabletting performance enhancement |
| Q47807784 | DNP-enhanced solid-state NMR spectroscopy of active pharmaceutical ingredients |
| Q51959166 | Determination of the polymorphic forms of bicifadine hydrochloride by differential scanning calorimetry-thermogravimetric analysis, X-ray powder diffraction, attenuated total reflectance-infrared spectroscopy, and attenuated total reflectance-near-i |
| Q39628531 | Discovery pharmaceutics--challenges and opportunities |
| Q42720527 | Disintegration mediated controlled release supersaturating solid dispersion formulation of an insoluble drug: design, development, optimization, and in vitro evaluation |
| Q51548600 | Early development drug formulation on a chip: fabrication of nanoparticles using a microfluidic spray dryer. |
| Q57174036 | Engineering Cocrystals of PoorlyWater-Soluble Drugs to Enhance Dissolution in Aqueous Medium |
| Q37261680 | Estimating the Aqueous Solubility of Pharmaceutical Hydrates |
| Q90869635 | Evaluation of Force-Field Calculations of Lattice Energies on a Large Public Dataset, Assessment of Pharmaceutical Relevance, and Comparison to Density Functional Theory |
| Q42272259 | Evidence of Polymorphism on the Antitrypanosomal Naphthoquinone (4E)-2-(1H-Pyrazol-3-ylamino)-4-(1H-pyrazol-3-ylimino)naphthalen-1(4H)-one |
| Q91736170 | Image-Based Investigation: Biorelevant Solubility of α and γ Indomethacin |
| Q34757166 | Impact of crystal polymorphism on the systemic bioavailability of rifaximin, an antibiotic acting locally in the gastrointestinal tract, in healthy volunteers. |
| Q36909306 | Impact of physiological, physicochemical and biopharmaceutical factors in absorption and metabolism mechanisms on the drug oral bioavailability of rats and humans |
| Q38093663 | Impact of preformulation on drug development |
| Q92869685 | Implication of Differential Surface Anisotropy on Biopharmaceutical Performance of Polymorphic Forms of Ambrisentan |
| Q46185895 | Improved dissolution of a poorly water soluble drug in solid dispersions with polymeric and non-polymeric hydrophilic additives |
| Q38850505 | In pursuit of functional electrospun materials for clinical applications in humans |
| Q51016701 | Insights into the crystallisation process from anhydrous, hydrated and solvated crystal forms of diatrizoic acid. |
| Q39522374 | Isolation and Physical Property Optimization of an Amorphous Drug Substance Utilizing a High Surface Area Magnesium Aluminometasilicate (Neusilin(®) US2). |
| Q40983414 | Microcrystalline preparation of akebia saponin D for its bioavailability enhancement in rats |
| Q35999134 | Modification of the solid-state nature of sulfathiazole and sulfathiazole sodium by spray drying |
| Q92506035 | Natural Deep Eutectic Solvents as Agents for Improving Solubility, Stability and Delivery of Curcumin |
| Q41871280 | Niosomal carriers enhance oral bioavailability of carvedilol: effects of bile salt-enriched vesicles and carrier surface charge. |
| Q58598426 | Overcoming the bile salt-mediated formation of nanocolloids that inhibit oral absorption of VX-985 |
| Q44209042 | Physicochemical characterization of phyllanthin from Phyllanthus amarus Schum. et Thonn |
| Q26779030 | Polymorph Impact on the Bioavailability and Stability of Poorly Soluble Drugs |
| Q38219628 | Preclinical formulations: insight, strategies, and practical considerations. |
| Q47364783 | Preparation and characterization of dipyridamole solid dispersions for stabilization of supersaturation: effect of precipitation inhibitors type and molecular weight |
| Q48244592 | Probing the effects of experimental conditions on the character of drug-polymer phase diagrams constructed using Flory-Huggins theory |
| Q36439180 | Recent progress in the computational prediction of aqueous solubility and absorption |
| Q42039804 | Release profile and characteristics of electrosprayed particles for oral delivery of a practically insoluble drug |
| Q92253102 | Solid-State Characterization of Spironolactone 1/3 Hydrate |
| Q49582108 | Solid-state characterization and impurities determination of fluconazol generic products marketed in Morocco. |
| Q34571106 | Solid-state characterization of nevirapine |
| Q108605989 | Solvent Screening for Solubility Enhancement of Theophylline in Neat, Binary and Ternary NADES Solvents: New Measurements and Ensemble Machine Learning |
| Q27658109 | Structural Studies of Pterin-Based Inhibitors of Dihydropteroate Synthase |
| Q92875382 | Synthesis of Novel 2-(Het)arylpyrrolidine Derivatives and Evaluation of Their Anticancer and Anti-Biofilm Activity |
| Q57166953 | The influence of solid state information and descriptor selection on statistical models of temperature dependent aqueous solubility |
| Q58860627 | Toward supramolecular architectures of the anti-HIV drug lamivudine: understanding the effect of the inclusion of water in a hydrochloride form |